Regulation of adaptive behaviour during fasting by hypothalamic Foxa2

Area of Science:

• Neuroscience
• Metabolic Regulation
• Molecular Biology

Background:

• The lateral hypothalamic area is a key brain region for regulating feeding behavior, arousal, and motivated actions.
• Orexin and melanin-concentrating hormone (MCH) are neuropeptides in the lateral hypothalamus that are inhibited by feeding and released during fasting.
• The precise molecular mechanisms integrating feeding-related signals and neuropeptide expression remain unclear.

Purpose of the Study:

• To investigate the role of the transcription factor Foxa2 in regulating orexin and MCH expression in the lateral hypothalamus.
• To elucidate how insulin signaling influences Foxa2 activity and subsequent neuropeptide expression.
• To determine the impact of Foxa2 manipulation on feeding behavior, metabolism, and glucose homeostasis.

Main Methods:

• Utilized genetic manipulation in mice to study Foxa2 function, including constitutive and conditional activation models.
• Examined the binding of Foxa2 to the promoters of MCH and orexin genes.
• Assessed the effects of Foxa2 activation on food consumption, body composition, physical activity, and insulin sensitivity.

Main Results:

• Foxa2 directly regulates the expression of orexin and MCH by binding to their promoters.
• Insulin signaling promotes nuclear exclusion of Foxa2, reducing MCH and orexin expression in fed and obese states.
• Constitutive or conditional activation of Foxa2 increased MCH and orexin expression, leading to enhanced food intake, metabolism, and insulin sensitivity, along with increased physical activity.

Conclusions:

• Foxa2 functions as a critical metabolic sensor in the lateral hypothalamic area.
• Foxa2 integrates metabolic signals to modulate feeding behavior, energy expenditure, and physiological responses.
• Targeting Foxa2 may offer therapeutic potential for metabolic disorders such as obesity and diabetes.